Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data

Abstract Objective Investigate effects of gender on disease characteristics and treatment impact in patients with PsA. Methods PsABio is a non-interventional European study in patients with PsA starting a biological DMARD [bDMARD; ustekinumab or TNF inhibitor (TNFi)]. This post-hoc analysis compared...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Rheumatology 2023-10, Vol.62 (10), p.3382-3390
Hauptverfasser:	Van Kuijk, Arno W R, Nurmohamed, Mike T, Siebert, Stefan, Bergmans, Paul, de Vlam, Kurt, Gremese, Elisa, Joven-Ibáñez, Beatriz, Korotaeva, T V, Lavie, Frederic, Sharaf, Mohamed, Noël, Wim, Theander, Elke, Smolen, Josef S, Gossec, Laure, van der Horst-Bruinsma, Irene E
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical Science Life Sciences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!